От идиопатического фиброзирующего альвеолита к идиопатическому легочному фиброзу(часть II)

Автор: Аверьянов Александр Вячеславович, Лесняк Виктор Николаевич

Журнал: Клиническая практика @clinpractice

Статья в выпуске: 4 (28), 2016 года.

Бесплатный доступ

Вторая часть аналитического обзора посвящена особенностям клинической картины, течения и диагностики идиопатического легочного фиброза. Большое внимание уделено специфическим симптомам при компьютерной томографии, позволяющим поставить диагноз, не прибегая к биопсии легкого. Обсуждены современные подходы к инвазивной диагностике, перспективы использования криозондов.

Идиопатический легочный фиброз, компьютерная томография высоких раз- решений, криобиопсия

Короткий адрес: https://sciup.org/143164618

IDR: 143164618

Список литературы От идиопатического фиброзирующего альвеолита к идиопатическому легочному фиброзу(часть II)

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;15:788-824.
Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006;3:285-292.
Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
Hopkins RB, Burke N, Fell C, et al. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada. Eur Respir J. 2016 May 26. pii: ERJ-01504-2015.
Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011; 66: 462-467
Larsen BT, Colby TV: Update for pathologists on idiopathic interstitial pneumonias. Arch Pathol Lab Med, 2012;136:1234-1241.
Аверьянов А.В., Лесняк В.Н., Коган Е.А. Редкие заболевания легких: диагностика и лечение (под ред. А.В. Аверьянова) М., МИА, 2016, 248 с.
Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 2012; 380(9842): 680-688.
Loomis-King H, Flaherty KR, Moore BB Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis. Curr Opin Pharmacol. 2013 Apr 18. pii: S1471-4892(13)00049-0.
Cordier JF, Cottin V. Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis Eur Respir J. 2013 Oct;42(4):916-23.
Richeldi L. du Bois RM, Raghu G, et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. New England J Med. 2014;370:2071-2082.
King T, Bradford W, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-92.
Nair GB, Matela A, Kurbanov D, Raghu G. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications Expert Rev Respir Med. 2016 Jun;10(6):699-711. 15 DOI: 10.1080/17476348.2016.1177461
Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 2014; 190: 773-779.
Atkins CP, Loke YK, Wilson AM. Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials. Respir Med 2014; 108: 376-387.
Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung 2012; 190: 373-380.
Ryerson CJ, Cottin V, Brown KK, Collard HR. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm. Eur Respir J. 2015 Aug; 46(2):512-20.
Collard HR, Ryerson CJ, Corte TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis: An International Working Group Report. Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI.
Kondoh Y, Taniguchi H, Katsuta T, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 103-110.
Collard HR, Tino G, Noble PW, et al. Patient experiences with pulmonary fibrosis. Respir Med. 2007;101:1350-1354.
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology 2008; 246:697-722.
Souza CA, Muller NL, Lee KS, et al. Idiopathic interstitial pneumonias: prevalence of mediastinal lymphnode enlargement in 206 patients. AJR Am J Roentgenol 2006;186: 995-999.
Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-593.
Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178: 372-378.
du Bois RM. An earlier and more confident diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2012 Jun 1;21(124):141-6.
Kendall DM, Gal AA. Interpretation of tissue artifacts in transbronchial lung biopsy specimens. Ann Diagn Pathol 2003;7(1):20-24.
Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24(6):1000-1006.
Lynch JP 3rd, Huynh RH, Fishbein MC, et al. Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management Semin Respir Crit Care Med. 2016 Jun;37(3):331-57.
Kondoh Y, Taniguchi H, Kitaichi M, et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 2006;100(10):1753-1759.
Nguyen W, Meyer KC. Surgical lung biopsy for the diagnosis of interstitial lung disease: a review of the literature and recommendations for optimizing safety and efficacy. Sarcoidosis Vasc Diffuse Lung Dis. 2013 Mar; 30(1):3-16.
Dhooria S, Sehgal I, Aggarwal A, et al. Diagnostic Yield and Safety of Cryoprobe Transbronchial Lung Biopsy in Diffuse Parenchymal Lung Diseases: Systematic Review and Meta-Analysis. Respir Care. 2016 May; 61(5):700-12.

Еще

Статья научная